Education
About Us
Working with TipRanks
Follow Us
Abbott Laboratories (ABT)
NYSE:ABT
ABT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$107.11 - $141.23
Previous CloseN/A
Volume1.03M
Average Volume (3M)6.95M
Market Cap
$233.71B
Enterprise Value$244.55B
Total Cash (Recent Filing)$6.84B
Total Debt (Recent Filing)$13.24B
Price to Earnings (P/E)16.8
Beta0.34
Next Earnings
Oct 15, 2025EPS Estimate
1.3Last Dividend Ex-Date
Jul 15, 2025Dividend Yield1.73%
Share Statistics
EPS (TTM)1.26
Shares Outstanding1,740,459,000
10 Day Avg. Volume5,716,722
30 Day Avg. Volume6,953,043
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)4.11
Price to Sales (P/S)4.67
P/FCF Ratio30.84
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue5.78
Enterprise Value/Gross Profit11.23
Enterprise Value/Ebitda21.94
Forecast
1Y Price Target
$144.83Price Target Upside7.86% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering20
Bulls Say, Bears Say
Bulls Say
Product PerformanceMultiple key growth drivers from ABT's MedTech segment showed continued strength, especially in Diabetes and EP.
Sales PerformanceLibre sales of $1.9 billion surpassed estimates, highlighting strong demand and growth in this product line.
Stock ValuationThe stock's reaction is seen as too punitive, presenting a buying opportunity as it has been upgraded to Buy.
Bears Say
Diagnostics Segment ChallengesSofter-than-expected COVID sales, ongoing disruption from VBP in China, and recent changes in HIV funding were largely responsible for lower-than-expected Diagnostics sales.
Guidance RevisionThe organic growth guide including covid was lowered to 6-7% from prior 7.5%.
Revenue DisruptionABT's non-MedTech segments, which account for about 55% of revenue, remain a source of disruption.
Abbott Laboratories News
ABT FAQ
What was Abbott Laboratories’s price range in the past 12 months?
Abbott Laboratories lowest stock price was $107.11 and its highest was $141.23 in the past 12 months.
What is Abbott Laboratories’s market cap?
Abbott Laboratories’s market cap is $233.71B.
When is Abbott Laboratories’s upcoming earnings report date?
Abbott Laboratories’s upcoming earnings report date is Oct 15, 2025 which is in 64 days.
How were Abbott Laboratories’s earnings last quarter?
Abbott Laboratories released its earnings results on Jul 17, 2025. The company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.256 by $0.004.
Is Abbott Laboratories overvalued?
According to Wall Street analysts Abbott Laboratories’s price is currently Undervalued.
Does Abbott Laboratories pay dividends?
Abbott Laboratories pays a Quarterly dividend of $0.59 which represents an annual dividend yield of 1.73%. See more information on Abbott Laboratories dividends here
What is Abbott Laboratories’s EPS estimate?
Abbott Laboratories’s EPS estimate is 1.3.
How many shares outstanding does Abbott Laboratories have?
Abbott Laboratories has 1,740,459,000 shares outstanding.
What happened to Abbott Laboratories’s price movement after its last earnings report?
Abbott Laboratories reported an EPS of $1.26 in its last earnings report, beating expectations of $1.256. Following the earnings report the stock price went down -8.524%.
Which hedge fund is a major shareholder of Abbott Laboratories?
Currently, no hedge funds are holding shares in ABT
Abbott Laboratories Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$144.83 (7.86% Upside)
$144.83 (7.86% Upside)
Blogger Sentiment
Bullish
ABT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 10.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.8%
Last 30 Days ▲ 3.7%
Last 30 Days ▲ 3.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.69%
12-Months-Change
Fundamentals
Return on Equity
31.01%
Trailing 12-Months
Asset Growth
15.04%
Trailing 12-Months
Company Description
Abbott Laboratories
Abbott Laboratories (ABT) is a global healthcare company that specializes in the development and marketing of a wide range of medical devices, diagnostics, nutrition products, and pharmaceuticals. Founded in 1888 and headquartered in Abbott Park, Illinois, the company operates through four main sectors: Established Pharmaceuticals, Diagnostic Products, Nutritional Products, and Medical Devices. Abbott is known for its innovative products, including glucose monitoring systems, heart devices, and nutritional supplements, catering to diverse health needs across all stages of life.
ABT Company Deck
ABT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Abbott experienced strong growth in several segments, particularly in Medical Devices and EPD, and achieved significant EPS growth. However, challenges persist in the Diagnostics segment due to declining COVID testing sales and issues in the China market. The impact of tariffs also presents a headwind, but overall performance remains resilient.View all ABT earnings summariesABT Net sales Breakdown
45.26% Medical Devices
22.27% Diagnostic Products
20.05% Nutritional Products
12.38% Established Pharmaceutical Products
0.04% Other
ABT Stock 12 Month Forecast
Average Price Target
$144.83
▲(7.86% Upside)
Technical Analysis
Ownership Overview
0.47% Insiders
26.05% Mutual Funds
0.83% Other Institutional Investors
52.37% Public Companies and Individual Investors